Anti-NMDAR encephalitis - rare complication after herpes virus encephalitis with a case report

Authors

  • Maya Koleva UHATNP „St. Naum”
  • V. Bojinova UHATNP "St.Naum"; Medical university – Sofia
  • F. Galabova UMHAT "St.Georgi"; Medical university – Plovdiv
  • I. Ivanov UMHAT "St.Georgi"; Medical university – Plovdiv
  • A. Mangarov SHATID „Prof. Ivan Kirov“ - Sofia; Medical university – Sofia

Keywords:

Herpes simplex encephalitis, Herpes simplex virus type 1 (HSV 1), Herpes simplex virus type 2 (HSV 2), autoimmune encephalitis, anti-NMDAR еncephalitis, anti NMDAR antibodies

Abstract

Herpes viral encephalitis are severely occurring diseases most commonly caused by HSV1 and HSV2 viruses. Characterized by severe leakage, significant lethality, especially in patients not treated with Aciclovir and persistent residual lesions. Although belonging to one group, the two viruses cause a different severity and localization clinic, with some age-specific features - HSV-1 is the most common among viral encephalitis. There is a characteristic temporal and temporopathic predisposition to brain damage and occurs predominantly at the age after 6 months of age. HSV-2 is found to be significantly less frequent with diffuse involvement of brain parenchyma, especially in newborns, as a result of infection due to female genital herpes infection. A combination of the two viruses is also possible, which determines even more significant injuries in the affected ones.
Anti-NMDAR encephalites belong to the group of autoimmune encephalitis - a group of heterogeneous diseases with underlying symptomsand diverse aetiology: idiopathic, post-infectious (viral, bactericidal), paraneoplastic and with a possible genetic predisposition. The greater incidence of this encephalitis in Herpes viral encephalitis with relevant extrapyramidal syndrome in infancy is known.
The purpose of this article is to provide a brief overview of the clinic, diagnosis and treatment of Herpes and anti-NMDAR encephalitis, as well as a verified case of Herpes encephalitis with established anti-NMDAR antibodies in CSF.

References

Bozhinova, V., Deneva, D., Asenova, A., Koleva, M., Rodopska, E., Topalov, N. Avtoimunni entsefaliti v det·skata vŭzrast - kriterii i algoritŭm za diagnostika i lechenie. Bŭlgarska nevrologiya, 2017, 18, 3, 194-200.

Bozhinova, V., Deneva, D., Asenova, A., Koleva, M., Rodopska, E., Topalov, N. Avtoimunni entsefaliti v det·skata vŭzrast - aktualna diagnostika i lechenie. Predstavyane na sluchaite. Pediatriya, 2018, 58, 1, 64-70.

Bozhinova, V., Ivanov, I., Litvinenko, I., Pacheva, I. Entsefaliti i entsefalopatii v det·skata vŭzrast - osobenosti v klinichnoto protichane, diagnostika i lechenie - pravila i algoritmi. Pediatriya, 2019, 59, 1, 7-16.

Koleva, M., Bozhinova, V., Deneva, D., Aleksandrova, I., Slavkova, E., Topalov, N. Kherpes simpleks entsefaliti – klinichna kharakteristika i posledstviyata v det·ska vŭzrast. Bŭlgarska nevrologiya, 2016, 17, 3, 237-244.

Milanov, I., Bozhinova, V., Ivanov, I. Natsionalen konsensus za diagnostika i lechenie na ostri i avtoimunni entsefaliti i virus indutsirani entsefalopatii. Bŭlgarska nevrologiya 2019, 20, Dopŭlnenie 3, 1-23.

Armangue, T., Petit-Pedrol, M., Dalmau, J. Autoimmune Encephalitis in Children. J Child Neurol. 2012, 27, 11, 1460–1469

Armangue, T. et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Annals of Neurology 2013.

Dalmau, J., Gleichman, A.J., Hughes, E.G., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008, 7, 1091–1098.

Dalmau, J., Lancaster, E., Martinez-Hernandez, E. et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011, 10, 63–74.

Graus F, et al. A clinical approach to diagnosis of autoimmune encephalitis Lancet Neurology 2016, 15, 4, 391-404.

Hacohen, Y., Devia, K., Pettingill, P. et al. N-methyl-D-Aspartate Receptor antibodies in Post-Herpes Simplex Encephalitis neurological Relapse. Mov Disord. 2014, 29, 1,90-96

Menkes, J.K., Sarnat, H.B., Maria, B.L. Infections of the Nervous SystemIn: Child Neurology Seventh Edition. Lippincott Williams & Wilkins, 2006, 483-485.

Newman, M.P., Blum, S.R., Wong, C. W. Autoimmune encephalitis. Intern Med J. 2016, 46, 2,148-157.

Nosadini, M, Mohammad, S.S., Corazza, F. et al. Herpes simplex virusinduced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev Med Child Neurol. 2017, 59, 8, 796-805.

Salih, M.A.M., Khashab, H., Hassan, H.H., Kentab, A.Y., Subaei, S., Zeidan, R.M., Al-Nasser, M. A Study on Herpes Simplex Encephalitis in 18 Children, Including 3 Relapses. The Open Pediatric Medicine Journal, 2009, 3, 48-57.

Titulaer, M.J., Lindsey McCracken, ., Gabilondo, I. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMethyl- D-Aspartate (NMDA) receptor encephalitis: a cohort study. Lancet Neurol. 2013, 12, 2, 157–165.

Published

30.06.2019

How to Cite

Koleva, M., Bojinova, V., Galabova, F., Ivanov, I., & Mangarov, A. (2019). Anti-NMDAR encephalitis - rare complication after herpes virus encephalitis with a case report. Bulgarian Neurology, 20(1), 38–42. Retrieved from https://www.nevrologiabg.com/journal/index.php/neurology/article/view/79

ARK